$12.35 +0.62 (5.29%) Sarepta Therapeutics Inc - NASDAQ

Feb. 12, 2016 | 04:00 PM
Key Statistics
Last Trade: 12.35
Trade Time: Feb 12 04:00 PM Eastern Daylight Time
Change: +0.62 (5.29%)
Prev Close: 11.73
Open: 11.83
Bid: 12.33
Ask: 12.34

Competitors

Ticker Name Volume % Change
PFE Pfizer Inc 32.54M +0.79%
MYL Mylan N.V. 15.53M +0.98%
MRK Merck & Co Inc 13.60M +0.37%
ABBV AbbVie Inc 9.98M +0.77%
JNJ Johnson & Johnson 9.04M +0.12%

SRPT Stock Analysis

  1. No results found.

Partner Headlines

  1. Sarepta Says FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to ...

    Benzinga | Jan. 20, 2016 | 19:44PM EST
  2. Benzinga's Top Downgrades

    Benzinga | Jan. 19, 2016 | 09:30AM EST
  3. Sarepta drops on FDA release

    IBD | Jan. 15, 2016 | 18:43PM EST
  4. Sarepta Plummets As FDA Slams Muscular Dystrophy Drug

    IBD | Jan. 15, 2016 | 12:53PM EST
  5. BioMarin Muscular Dystrophy Drug Rejected By FDA

    IBD | Jan. 14, 2016 | 12:29PM EST
  6. FDA Panel Seen As Bad For BioMarin, Good For Sarepta

    IBD | Nov. 25, 2015 | 14:34PM EST